resiquimod has been researched along with GRL-0617 in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (GRL-0617) | Trials (GRL-0617) | Recent Studies (post-2010) (GRL-0617) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 13 | 0 | 12 |
| Protein | Taxonomy | resiquimod (IC50) | GRL-0617 (IC50) |
|---|---|---|---|
| Spike glycoprotein | Betacoronavirus England 1 | 0.6 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 0.6 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 0.6 | |
| Procathepsin L | Homo sapiens (human) | 0.6 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 0.6 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 0.6 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 1.1567 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 2.1191 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 0.6 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for resiquimod and GRL-0617
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |